Stability of radioactive colloids for radiation synovectomy: influence of x-ray contrast agents, anaesthetics and glucocorticoids in vitro

Nuclear Medicine Communications

Volumn 26, Issue 11, 2005, Pages 1027-1035

  Schomäcker, Klaus ^a   Dietlein, Markus ^b   Mödder, Gynter ^b   Boddenberg Pätzold, Barbara ^b   Zimmermanns, Beate ^b   Fischer, Thomas ^b   Schicha, Harald ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Practice for Radiology and Nuclear Medicine   (Germany)

Author keywords

Anaesthetics; Erbium 169; Glucocorticoids; Radiation synovectomy; Radiochemical purity; Rhenium 186; X ray contrast agent; Yttrium 90

Indexed keywords

ANESTHETIC AGENT; CONTRAST MEDIUM; EDETIC ACID; ERBIUM CITRATE ER 169; GLUCOCORTICOID; IOPROMIDE; IOTROLAN; MEGLUMINE IOTALAMATE; MEPIVACAINE; RADIOACTIVE MATERIAL; RHENIUM SULFIDE RE 186; TRIAMCINOLONE; UNCLASSIFIED DRUG; YTTRIUM CITRATE Y 90;

ARTICLE; CENTRIFUGATION; COLLOID; DRUG STABILITY; IN VITRO STUDY; MOLECULAR WEIGHT; RADIOSURGERY; SYNOVECTOMY; SYNOVIAL FLUID; THIN LAYER CHROMATOGRAPHY; ULTRAFILTRATION;

ANESTHETICS; COLLOIDS; CONTRAST MEDIA; DRUG COMBINATIONS; DRUG STABILITY; GLUCOCORTICOIDS; HALF-LIFE; HUMANS; JOINT DISEASES; RADIOISOTOPES; RADIOMETRY; RADIOPHARMACEUTICALS;

EID: 27344458235     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000183801.20018.f8     Document Type: Article

References (37)

1. 90Y colloids. Br J Radiol 1975; 48:377-381.
2. 90Y) for the treatment of chronic knee effusions. Br J Radiol 1970; 43:466-470.
3. Sledge CB, Atcher RW, Shortkroff S, Anderson RJ, Bloomer WD, Hurson BJ. Intra-articular radiation synovectomy. Clin Orthop 1984; 182:37-40.
4. Mumper RJ, Mills BJA, Ryo UY, Jay M. Polymeric microspheres for radionuclide synovectomy containing neutron-activated holmium-166. J Nucl Med 1992; 33:398-402.
5. Chinol M, Vallabhajosula S, Goldsmith SJ, Klein MJ, Deutsch KF, Chinen LK, et al. Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. J Nucl Med 1993; 34:1536-1542.
6. Mödder G. Radiosynoviorthesis. Involvement of Nuclear Medicine in Rheumatology and Orthopaedics. Meckenheim: Warlich Druck; 1995 (reprint 2001).
7. Fischer M, Mödder G. Radionuclide therapy of inflammatory joint diseases. Nucl Med Commun 2002; 23:829-831.
8. Rau H, Lohmann K, Franke C, Goretzki G, Lemb MA, Müller J, et al. Multicenter study of radiosynoviorthesis. Clinical outcome in osteoarthritis and other disorders with concomitant synovitis in comparison with rheumatoid arthritis. Nuklearmedizin 2004; 43:57-62.
9. 99mTc-dextran scintigraphy to detect disease activity in patients with rheumatoid arthritis. Nucl Med Commun 2004; 25:597-601.
10. 90Y phosphate particles as a possible radiation synoviorthesis agent. Nucl Med Commun 2005; 26:459-463.
11. Clunie G, Fischer M for the EANM Radionuclide Therapy Committee. EANM procedure guidelines for radiosynovectomy. Eur J Nucl Med Mol Imaging 2003; 30:BP12-BP16.
12. Schneider P, Farahati J, Reiners C. Radiosynovectomy in rheumatology, orthopedics, and hemophilia. J Nucl Med 2005; 46:48S-54S.
13. Siegel ME, Siegel HJ, Luck JV. Radiosynovectomy's clinical applications and cost effectiveness: a review. Semin Nucl Med 1997; 27:364-371.
14. Kröger S, Sawula JA, Klutmann S, Brenner W, Bohuslavizki KH, Henze E, et al. Effect of radiosynovectomy in patients with inflammatory joint disorders not caused by rheumatoid arthritis. Nuklearmedizin 1999; 38:279-284.
15. Rozeboom S, Dörr U, Bihl H. Radiosynovectomy for the treatment of rheumatoid arthritis of the elbow. Nuklearmedizin 2001; 40:91-97.
16. Farahati J, Reiners C, Fischer M, Mödder G, Franke C, Mahlstedt J, et al. Leitlinie fu¨r die Radiosynoviorthese. Nuklearmedizin 1999; 38:254-255.
17. Schomäcker K, Beyer GJ, Franke WG, Shukla SK. Radiopharmacology of radioactive metal-ligand-complexes. Isotopenpraxis 1990; 26:145-149.
18. Kutzner J, Alfter G, Grimm W. Changing of organ distribution of radioactive yttrium in rats by varying amounts of carrier. Nuklearmedizin 1986; 25:78-80.
19. Saha GB. Fundamentals of Nuclear Pharmacy, 3rd edition. New York: Springer Verlag; 1992.
20. Almen T. Contrast media: the relation of chemical structure, animal toxicity and adverse clinical effects. Am J Cardiol 1990; 66:2F-8F.
21. Bourin M, Jolliet P, Ballereau F. An overview of the clinical pharmacokinetics of X-ray contrast media. Clin Pharmacokinet 1997; 32:180-193.
22. Gaspari F, Perico N, Remuzzi G. Measurement of glomerular filtration rate. Kidney Int Suppl 1997; 63:151-154.
23. Krause W, Miklautz H, Kollenkirchen U, Heimann G. Physicochemical parameters of X-ray contrast media. Invest Radiol 1994; 29:72-80.
24. Krause W, Niehues D. Biochemical characterisation of X-ray contrast media. Invest Radiol 1996; 31:30-42.
25. Krause W, Schromm M. Use of additives to contrast media to improve imaging in plain film and computed tomography urography. Invest Radiol 2003; 38:17-26.
26. Stacul F. Current iodinated contrast media. Eur Radiol 2001; 11:690-697.
27. Brossel R. Iopromide in angiography. Review of the literature. Ann Radiol (Paris) 1989; 32:361-368.
28. Schomäcker K, Mocker D, Münze R, Beyer GJ. Stabilities of lanthanide-protein complexes. Int J Rad Appl Instrum [A] 1988; 39:261-264.
29. Sotogaku N, Endo K, Hirunuma R, Enomoto S, Ambe S, Ambe F. Binding properties of various metals to blood components and serum proteins: a multitracer study. J Trace Elem Med Biol 1999; 13:1-6.
30. Rosoff B, Spencer H. Binding of rare earths to serum proteins and DNA. Clin Chim Acta 1979; 93:311-319.
31. Puchkova SM. Role of tissue proteins in the fixation of several radioactive isotopes. Radiobiologiya 1969; 9:108-110.
32. Liubashevskii NM. Effect of binding of strontium, yttrium and caesium isotopes by blood proteins on their accumulation in tissues. Radiobiologiya 1968; 8:754-755.
33. Peacocke AR, Williams PA. Binding of calcium, yttrium and thorium to a glycoprotein from bovine cortical bone. Nature 1966; 211:1140-1141.
34. Ohyoshi E, Kohata S. The binding of Yb(III) and Gd(III) to bovine serum albumin by a competitive spectrophotometry. J Inorg Biochem 1993; 52:157-163.
35. 169Yb binding substances in tumor tissues and liver. Eur J Nucl Med 1982; 7:298-303.
36. Franssen MJ, Koenders EB, Boerbooms AM, Buijs WC, Lemmens JA, van de Putte LB. Does application of radiographic contrast medium in radiation synovectomy influence the stability of yttrium-90 colloid? Br J Rheumatol 1997; 36:506-508.
37. Gronewaller EF, Wahl HG, Kehlbach R, Rodemann HP, Claussen CD, Duda SH. Stability of iodinated contrast media in UV-laser irradiation and toxicity of the photoproducts. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1998; 169:537-541.